Bank of New York Mellon’s Mandiant, Inc. Common Stock MNDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,807,031
| Closed | -$39.4M | – | 4627 |
|
|
2022
Q2 | $39.4M | Buy |
1,807,031
+995,824
| +123% | +$21.9M | 0.01% | 1134 |
|
|
2022
Q1 | $18.1M | Sell |
811,207
-4,896
| -0.6% | -$90.6K | ﹤0.01% | 1731 |
|
|
2021
Q4 | $14.3M | Sell |
816,103
-36,841
| -4% | -$647K | ﹤0.01% | 1910 |
|
|
2021
Q3 | $15.2M | Sell |
852,944
-279,216
| -25% | -$5.3M | ﹤0.01% | 1876 |
|
|
2021
Q2 | $22.9M | Buy |
1,132,160
+346,866
| +44% | +$7.11M | ﹤0.01% | 1655 |
|
|
2021
Q1 | $15.4M | Sell |
785,294
-107,873
| -12% | -$2.25M | ﹤0.01% | 1853 |
|
|
2020
Q4 | $20.6M | Buy |
893,167
+10,981
| +1% | +$169K | ﹤0.01% | 1620 |
|
|
2020
Q3 | $10.9M | Buy |
882,186
+8,039
| +0.9% | +$110K | ﹤0.01% | 1809 |
|
|
2020
Q2 | $10.6M | Sell |
874,147
-38,980
| -4% | -$452K | ﹤0.01% | 1795 |
|
|
2020
Q1 | $9.66M | Buy |
913,127
+52,512
| +6% | +$755K | ﹤0.01% | 1713 |
|
|
2019
Q4 | $14.2M | Buy |
860,615
+56,485
| +7% | +$906K | ﹤0.01% | 1773 |
|
|
2019
Q3 | $10.7M | Sell |
804,130
-18,292
| -2% | -$260K | ﹤0.01% | 1883 |
|
|
2019
Q2 | $12.2M | Sell |
822,422
-44,888
| -5% | -$688K | ﹤0.01% | 1845 |
|
|
2019
Q1 | $14.6M | Sell |
867,310
-41,719
| -5% | -$702K | ﹤0.01% | 1755 |
|
|
2018
Q4 | $14.7M | Buy |
909,029
+127,785
| +16% | +$2.29M | ﹤0.01% | 1682 |
|
|
2018
Q3 | $13.3M | Buy |
781,244
+7,437
| +1% | +$119K | ﹤0.01% | 1873 |
|
|
2018
Q2 | $11.9M | Buy |
773,807
+775
| +0.1% | +$13.5K | ﹤0.01% | 1926 |
|
|
2018
Q1 | $13.1M | Buy |
773,032
+12,022
| +2% | +$194K | ﹤0.01% | 1845 |
|
|
2017
Q4 | $10.8M | Buy |
761,010
+15,343
| +2% | +$233K | ﹤0.01% | 1954 |
|
|
2017
Q3 | $12.5M | Buy |
745,667
+29,157
| +4% | +$448K | ﹤0.01% | 1875 |
|
|
2017
Q2 | $10.9M | Buy |
716,510
+83,564
| +13% | +$1.19M | ﹤0.01% | 1911 |
|
|
2017
Q1 | $7.98M | Buy |
632,946
+43,787
| +7% | +$522K | ﹤0.01% | 2083 |
|
|
2016
Q4 | $7.01M | Buy |
589,159
+71,979
| +14% | +$934K | ﹤0.01% | 2148 |
|
|
2016
Q3 | $7.62M | Sell |
517,180
-25,660
| -5% | -$394K | ﹤0.01% | 2002 |
|
|
2016
Q2 | $8.94M | Sell |
542,840
-13,650
| -2% | -$221K | ﹤0.01% | 1911 |
|
|
2016
Q1 | $10M | Sell |
556,490
-7,959
| -1% | -$130K | ﹤0.01% | 1837 |
|
|
2015
Q4 | $11.7M | Sell |
564,449
-4,776
| -0.8% | -$120K | ﹤0.01% | 1747 |
|
|
2015
Q3 | $18.1M | Buy |
569,225
+185,328
| +48% | +$7.73M | 0.01% | 1477 |
|
|
2015
Q2 | $18.8M | Buy |
383,897
+100,994
| +36% | +$4.57M | 0.01% | 1530 |
|
|
2015
Q1 | $11.1M | Buy |
282,903
+26,508
| +10% | +$1.02M | ﹤0.01% | 1890 |
|
|
2014
Q4 | $8.1M | Buy |
256,395
+8,476
| +3% | +$260K | ﹤0.01% | 2038 |
|
|
2014
Q3 | $7.58M | Buy |
247,919
+35,981
| +17% | +$1.19M | ﹤0.01% | 2067 |
|
|
2014
Q2 | $8.59M | Buy |
211,938
+143,032
| +208% | +$5.58M | ﹤0.01% | 2016 |
|
|
2014
Q1 | $4.24M | Buy |
68,906
+24,482
| +55% | +$1.74M | ﹤0.01% | 2405 |
|
|
2013
Q4 | $1.94M | Buy |
+44,424
| New | +$1.74M | ﹤0.01% | 2911 |
|
Other funds holding MNDT
Bank of New York Mellon's MNDT Position: Q3 2022 in Review
Bank of New York Mellon sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2022, closing a stake of 1,807,031 shares — an estimated $39.4M sold.
Bank of New York Mellon first reported a position in MNDT in Q4 2013 and held it in 35 quarters. The position peaked at $39.4M in Q2 2022. 3 funds tracked by Wall St. Rank hold MNDT as of Q3 2022.
- Bank of New York Mellon reported no remaining Mandiant, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Bank of New York Mellon sold 1,807,031 Mandiant, Inc. Common Stock shares in Q3 2022, an estimated $39.4M.
- Bank of New York Mellon first reported a position in Mandiant, Inc. Common Stock in Q4 2013 and held it in 35 quarters.
- Bank of New York Mellon's Mandiant, Inc. Common Stock position peaked at $39.4M in Q2 2022.
- 3 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2022.
Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.